A study led by TGen researchers has found that certain genes are believed to be associated with suicide, which could lead to better treatments for those who are experiencing suicidal thoughts.
Arizona State University’s Biodesign Institute has received $5.2 million from the Michael J. Fox Foundation to explore three potential treatments for Parkinson’s disease, with funded projects ranging from animal studies to a human clinical trial in partnership with Barrow Neurological Institute and the University of Arizona.
Here’s how Metro Phoenix is attracting more venture capital / AZ Big Media
Historically, Arizona hasn’t been a top contender for venture capital, but experts at AZBio and Startup AZ say the state is becoming a magnet for venture capital.
Global investor taking majority stake in longtime Valley medtech company Cranial Technologies / Phoenix Business Journal
Cranial Technologies, a Phoenix-based medical technology company that is the market leader in treating infant plagiocephaly, is getting a new majority investor as it continues a strategy of growth domestically and internationally.
Arizona’s rural areas, primary-care needs hit hardest by doctor shortage / Arizona Daily Star
Arizona urgently needs doctors who provide basic and routine care—and that’s likely to increase dramatically over the next decade as the state’s population continues to grow and an increasing number of physicians reach retirement age.
On second anniversary, COVID-19 still racks up grim milestones in Arizona / Phoenix Business Journal
Two years after Arizona’s first confirmed case of COVID-19, the state has racked up close to 1.8 million infections and the virus has killed almost 26,000 with the rate of COVID-19 deaths second-highest in the nation. Read more: Arizona marks 2 years since state’s first COVID-19 case
The Lab at azcentral, which launches Jan. 31, will take listeners across Arizona to answer bioscience questions big and small.
January 27: 2022 AZBio Kickoff Reception
February 3: State of the Innovation Scene in Arizona (CLE Lunch Panel Discussion)